Prognosis
Chest CT–based Assessment of 1-year Outcomes after Moderate COVID-19 Pneumonia
Radiology. 2022 Nov;305(2):479-485
Long-term neurologic outcomes of COVID-19
Nat Med. 2022 Nov;28(11):2406-2415
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study
Lancet Rheumatol. 2022 Nov;4(11):e765-e774
Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study
EBioMedicine. 2022 Oct;84:104245
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
Heart. 2022 Oct 24;heartjnl-2022-321492.
Post-acute sequelae of covid-19 six to 12 months after infection: population based study
BMJ. 2022 Oct 13;379:e071050
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study
Nat Commun. 2022 Oct 12;13(1):5663
Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study
Lancet Glob Health. 2022 Sep;10(9):e1247-e1256
Association of COVID-19 vs Influenza With Risk of Arterial and Venous Thrombotic Events Among Hospitalized Patients
JAMA. 2022 Aug 16;328(7):637-651
Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study
Lancet. 2022 Aug 6;400(10350):452-461
Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves
BMJ. 2022 Jul 27;378:e069503
SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022
Euro Surveill. 2022 Jun;27(22):2200396
Persistent COVID-19 symptoms in a community study of 606,434 people in England
Nat Commun. 2022 Apr 12;13(1):1957.
Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study
BMJ. 2022 Apr 6;377:e069590
Long-Term Cardiovascular Disease Following COVID-19
Nature Medicine 28, 583–590 (2022)
Long COVID occurrence in COVID-19 survivors
Sci Rep. 2022 Apr 11;12(1):6039.
SARS-CoV-2 is associated with changes in brain structure in UK Biobank
Nature. 2022 Mar 7
Performance of NEWS, qSOFA, and SIRS Scores for Assessing Mortality, Early Bacterial Infection, and Admission to ICU in COVID-19 Patients in the Emergency Department
Front Med (Lausanne). 2022 Mar 2;9:779516
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19
JAMA. 2022 Feb 8;327(6):559-565.
Association of SARS-CoV-2 Infection With Serious Maternal Morbidity and Mortality From Obstetric Complications
JAMA. 2022 Feb 22;327(8):748-759.
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Nat Immunol. 2022 Feb;23(2):210-216.
Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19
Euro Surveill. 2022 Jan;27(1):2001848.
Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb
Cell. 2021 Nov 24;184(24):5932-5949.e15.
Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors
Endocrinol Metab (Seoul). 2021 Jun;36(3):582-589.
More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
Sci Rep. 2021 Aug 9;11(1):16144.
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Lancet Respir Med. 2021 Jul;9(7):747754.
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
BMJ. 2021 May 13;373:n1088.
Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study
BMJ. 2021 May 19;373:n1098.
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study.
Lancet Rheumatol. 2021 May 25.
Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies.
Acta Obstet Gynecol Scand. 2020 Apr 07.
Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes
JAMA. 2021;325(20):2076-2086.
Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.
Published on March 27 2020, at NEJM.org DOI: 10.1056/NEJMoa2005412
Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients From Wuhan, China.
Intensive Care Med 2020 Mar 3[Online ahead of print]
Clinical Course and Risk Factors for Mortality of Adult Inpatients With COVID-19 in Wuhan, China: A Retrospective Cohort Study.
Lancet, 395, 1054-1062, 2020 Mar 28
Clinical Characteristics of 113 Deceased Patients With Coronavirus Disease 2019: Retrospective Study.
BMJ, 368, m1091, 2020 Mar 26
Analysis of Factors Associated With Disease Outcomes in Hospitalized Patients With 2019 Novel Coronavirus Disease.
Chin Med J (Engl) 2020 Feb 28[Online ahead of print]
The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China.
Zhonghua Liu Xing Bing Xue Za Zhi, 41 (2), 145-151, 2020 Feb 17[Online ahead of print] [Article in Chinese]
